← Eichor
Study identifier: NCT07237516 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Condition: Ulcerative Colitis (UC) · Crohn's Disease (CD) · Indeterminate Colitis  ·  Sponsor: University of North Carolina, Chapel Hill

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does Zymfentra lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed Zymfentra (IFX-dyyb as part of their regular medical care for CD or UC will answer online survey questions about their bowel habits for 1 year.

This description comes directly from the study's public registry record.

Talk to the study team

Susan Jackson  ·  919-843-9071  ·  susan_jackson@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (9)

Yale University School of MedicineNew Haven, Connecticut, United StatesRecruiting
University of IowaIowa City, Iowa, United StatesRecruiting
Mercy Medical CenterBaltimore, Maryland, United StatesRecruiting
Brigham and Women's HospitalBoston, Massachusetts, United StatesRecruiting
New York UniversityNew York, New York, United StatesRecruiting
University of North CarolinaChapel Hill, North Carolina, United StatesRecruiting
Atrium Health Center for Gastroenterology and SurgeryCharlotte, North Carolina, United StatesRecruiting
Wake Forest School of MedicineWinston-Salem, North Carolina, United StatesRecruiting
University of CincinnatiCincinnati, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07237516